Office of Research Compliance News

Revised Controlled Substances Policy and Forms Effective June 1, 2016

Posted: May 31, 2016

Revised Controlled Substances Policy and Forms Effective June 1, 2016

The Individual Investigator Use of Controlled Substances in Non-Therapeutic Research policy describes the responsibilities of the university, registrants, and authorized agents who use controlled substances in animal, cell culture, or in-vitro analytical laboratory research and, specifically, their responsibilities to comply with DEA and State of Ohio Board of Pharmacy requirements concerning the administration, handling, storage, destruction, and/or transfer of controlled substances used in such research.

The revision of the policy:

  • incorporates regulations changes,
  • requires background checks to be performed for anyone with access to the controlled substances,
  • centralizes registration and administration at the college level,
  • sets training and inspection standards,
  • standardizes recordkeeping requirements,
  • formalizes current university practices and provides clarity for a university-wide audience.

An overview of the University’s controlled substances program as well as the updated, required forms to be used for documenting the receipt, use, waste, loss/theft, transfer, or disposal of controlled substances in research as well as authorized agent lists are available on the “Controlled Substances” page of our Office of Research Compliance website: http://orc.osu.edu/regulations-policies/controlled-substances/.

For answers to frequently asked questions, visit http://orc.osu.edu/regulations-policies/controlled-substances/faqs/.

View the entire revised Individual Investigator Use of Controlled Substances in Non-Therapeutic Research policy here:  http://policies.osu.edu/

Category : General